Want to join the conversation?
Maker of genetic pharmaceutical products $LCI said that its President, Michael J. Bogda, is resigning from the company, effective June 3, 2016, to pursue other interests. CEO Arthur Bedrosian said that Mr. Bogda spearheaded the integration of $LCI's two most recent acquisitions, Kremers Urban Pharmaceuticals and Silarx Pharmaceuticals.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?